| Particulars |
| Company Name |
Novartis India Ltd |
Year End |
202603 |
| Full Year |
| Equity (Rs Cr.) |
12.35 |
B.V. Rs |
331.20 |
| Sales Rs Cr. |
376.96 |
NP Rs Cr. |
93.20 |
| NP Var% |
-8.00 |
Div% |
500.00 |
| CPS Rs |
38.50 |
EPS Rs |
37.70 |
| Traded Value(Rs Lakhs) |
235.30 |
52 Week High |
2,588.00 |
| 52 Week Low |
750.00 |
Price BSE |
1,835.00 |
| Price NSE |
1,825.00 |
Market Capital(Rs Cr.) |
4,530.14 |
| P/C Ratio |
47.60 |
P/E Ratio |
48.60 |
| Price Vs.BV |
5.54 |
|
| Latest Quarter |
| Year End |
202606 |
Sales Rs Cr. |
103.81 |
| NP Rs Cr. |
32.21 |
NP Var % |
17.00 |
| Trailing Twelve Months |
| Year End |
202606 |
Sales |
345.11 |
| OPM |
21.13 |
NP |
87.40 |
| NP Var% |
-4.87 |
EPS |
39.60 |
| PE |
46.33 |
|
|